Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Review Article November 27 2024
Is Allogeneic Transplantation for Sickle Cell Disease Still Relevant in the Era of Gene Therapy?
Letter November 27 2024
Genomic landscape of testicular follicular lymphoma is characterized by frequent 1p36/TNFRSF14 alterations
Letter November 27 2024
Deficit accumulation frailty index (DAFI) and treatment tolerability in AML: Data from CALGB 11001 and 11002 (Alliance)
Letter November 27 2024
Optical genome mapping identified deletions, inversions, and insertions in hemophilia
Research Article November 22 2024
PET/CT-derived coronary calcium score may predict cardiac complications in anthracycline-treated lymphoma patients
Research Article November 22 2024
MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma
Research Article November 21 2024
Impact of prior CAR-T cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas
Research Article November 21 2024
Incidence and Characterization of Secondary CNS Lymphoma in 1,972 Patients with DLBCL - A Danish Nationwide Cohort Study
Letter November 21 2024
T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia.
Research Article November 21 2024
Chronic Inflammation Deters Natural Killer Cell Fitness and Cytotoxicity in Myeloid Leukemia
Letter November 20 2024
Therapies and outcomes following extramedullary relapse of pediatric and young adult ALL after CD19 CAR T-cell therapy
Research Article November 20 2024
PTCy Based Graft versus Host Disease Prophylaxis for Matched Sibling Donor Allogeneic Hematopoietic Cell Transplantation
Research Article November 19 2024
Anti-leukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models
Research Article November 19 2024
Changes in gut microbiota predict neutropenia after induction treatment in childhood acute lymphoblastic leukemia
Review Article November 19 2024
CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease
Research Article November 19 2024
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis
Review Article November 19 2024
Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL
Research Article November 15 2024
A real-world comparison of commercial use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma
Research Article November 15 2024
ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development.
Letter November 15 2024
MRD-negative duration following latest line of therapy predicts long-term PFS in real-world multiple myeloma patients
Research Article November 15 2024
Cerebral vascular shunting and oxygen metabolism in sickle cell disease
Research Article November 15 2024
Venetoclax plus low intensity chemotherapy for adults with acute lymphoblastic leukemia
Research Article November 13 2024
Utility of Caregiver Signaling Questions to Detect Neurocognitive Impairment in Children with Sickle Cell Disease
Research Article November 13 2024
Diagnosis of TP53-mutated myeloid disease by the ICC and WHO 5th Edition Classifications
Research Article November 13 2024
Identification of Genomic Biomarkers of Disease Progression and Survival in Primary CNS Lymphoma
Letter November 13 2024
Pediatric refractory ITP, a definition to be defined
Research Article November 13 2024
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study
Research Article November 12 2024
Medicaid Coverage Continuity is Associated with Lymphoma Stage among Children and Adolescents/Young Adults
Research Article November 8 2024
Increased exercise tolerance in humanized G6PD deficient mice
Research Article November 6 2024
Validation of the Revised 2022 European LeukemiaNet Risk Stratification in Adult Patients with Acute Myeloid Leukemia
Research Article November 6 2024
Use of Affimer Technology for Inhibition of α2-antiplasmin and Enhancement of Fibrinolysis
Research Article November 6 2024
Donor age contributes more to the rheological properties of stored red blood cells than donor sex and biological age
Research Article October 31 2024
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium
Research Article October 29 2024
Hematopoietic Cell Transplant compared with Standard Care in Adolescents and Young Adults with Sickle Cell Disease
Research Article October 29 2024
Lymphopenia Predicts Poor Outcomes in Newly Diagnosed Multiple Myeloma
Research Article October 29 2024
Development of iPSC-derived human bone marrow organoid for autonomous hematopoiesis and patient-derived HSPC engraftment
Research Article October 29 2024
Divergent Modulation of Activated Protein C Pleiotropic Functions by Antibodies That Differ by A Single Amino Acid
Letter October 29 2024
The E3 ubiquitin ligase MARCH5 promotes mitochondrial fusion and cell cycle progression in acute myeloid leukemia
Research Article October 29 2024
Cancer cachexia and weight loss prior to CAR T-cell therapy for lymphoma are independently associated with poor outcomes
Letter October 29 2024
Achieving Equitable Care in Pulmonary Embolism: Exploring the Potential of Pulmonary Embolism Response Teams
Letter October 25 2024
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
Research Article October 25 2024
Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS
Reply October 25 2024
Reply to Letter to Editor by Fingrut, et al
Research Article October 25 2024
Recombinant Erwinia Asparaginase (JZP458) in ALL/LBL: Complete Follow-Up of the Children's Oncology Group AALL1931 Study
Research Article October 25 2024
Ibrutinib for therapy of steroid-refractory chronic graft vs. host disease: A multicenter real-world analysis
Research Article October 22 2024
Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Related CRS and ICANS - A Multicenter Retrospective Analysis
Research Article October 22 2024
Elritercept, a Modified Activin Receptor IIA Ligand Trap, increased Erythropoiesis and Thrombopoiesis in a Phase 1 Trial
Review Article October 22 2024
ASH living guidelines on use of anticoagulation for thromboprophylaxis in patients with COVID-19: executive summary
Letter October 22 2024
Is GPIbα really a master regulator of platelet activation?
Research Article October 17 2024
Gene Therapy in Transfusion-Dependent Non-β0/β0 Genotype β-Thalassemia: First Real-World Experience of Beti-cel
Page 2 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals